Jann‐Yuan Wang

8.4k total citations
242 papers, 5.3k citations indexed

About

Jann‐Yuan Wang is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Jann‐Yuan Wang has authored 242 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Infectious Diseases, 139 papers in Epidemiology and 80 papers in Surgery. Recurrent topics in Jann‐Yuan Wang's work include Tuberculosis Research and Epidemiology (126 papers), Mycobacterium research and diagnosis (73 papers) and Diagnosis and treatment of tuberculosis (34 papers). Jann‐Yuan Wang is often cited by papers focused on Tuberculosis Research and Epidemiology (126 papers), Mycobacterium research and diagnosis (73 papers) and Diagnosis and treatment of tuberculosis (34 papers). Jann‐Yuan Wang collaborates with scholars based in Taiwan, United States and China. Jann‐Yuan Wang's co-authors include Li‐Na Lee, Chong‐Jen Yu, Chin‐Chung Shu, Pan‐Chyr Yang, Po‐Ren Hsueh, Chih‐Hsin Lee, Jann‐Tay Wang, Meng‐Rui Lee, Hsin‐Chih Lai and Ming‐Chia Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jann‐Yuan Wang

235 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jann‐Yuan Wang Taiwan	41	2.9k	2.8k	1.5k	973	402	242	5.3k
Gee Young Suh South Korea	45	1.3k 0.5×	2.9k 1.0×	1.7k 1.1×	2.7k 2.8×	644 1.6×	360	7.6k
Mohammad Reza Masjedi Iran	32	2.3k 0.8×	2.0k 0.7×	1.2k 0.8×	646 0.7×	496 1.2×	341	4.7k
Sheldon T. Brown United States	34	1.7k 0.6×	2.1k 0.7×	446 0.3×	367 0.4×	283 0.7×	113	4.0k
Neil W. Schluger United States	42	3.9k 1.4×	2.9k 1.0×	1.7k 1.1×	547 0.6×	423 1.1×	122	5.8k
Marc Lipman United Kingdom	51	6.2k 2.2×	4.8k 1.7×	2.2k 1.4×	492 0.5×	750 1.9×	292	9.2k
Young Ae Kang South Korea	36	2.0k 0.7×	2.3k 0.8×	1.4k 0.9×	1.0k 1.0×	618 1.5×	262	4.8k
Kyeongman Jeon South Korea	47	3.5k 1.2×	5.4k 1.9×	1.9k 1.2×	2.1k 2.2×	352 0.9×	359	8.8k
George A. Sarosi United States	49	2.8k 1.0×	5.3k 1.9×	2.6k 1.7×	1.6k 1.6×	706 1.8×	242	10.2k
Dixie E. Snider United States	39	4.3k 1.5×	3.5k 1.3×	2.4k 1.6×	310 0.3×	317 0.8×	78	6.2k
Ritesh Agarwal India	62	5.6k 1.9×	3.2k 1.2×	2.1k 1.4×	7.9k 8.1×	642 1.6×	562	14.3k

Countries citing papers authored by Jann‐Yuan Wang

Since Specialization

Citations

This map shows the geographic impact of Jann‐Yuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jann‐Yuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jann‐Yuan Wang more than expected).

Fields of papers citing papers by Jann‐Yuan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jann‐Yuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jann‐Yuan Wang. The network helps show where Jann‐Yuan Wang may publish in the future.

Co-authorship network of co-authors of Jann‐Yuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jann‐Yuan Wang. A scholar is included among the top collaborators of Jann‐Yuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jann‐Yuan Wang. Jann‐Yuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Cheng‐Maw, Chi‐Chuan Yeh, Jann‐Yuan Wang, Rey‐Heng Hu, & Po‐Huang Lee. (2025). Preclass video nanolearning or microlearning in blended medical education. Frontiers in Medicine. 12. 1639475–1639475.

Lin, Tzu-Lung, Chia-Chen Lu, Chang‐Tsu Yuan, et al.. (2024). Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease. Gut Microbes. 16(1). 2361490–2361490. 8 indexed citations

Liang, Sheng‐Kai, Li‐Ta Keng, Meng‐Rui Lee, et al.. (2023). Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients. Cancer Medicine. 12(17). 17993–18004. 3 indexed citations

Chang, Chia‐Hao, Lih‐Yu Chang, Jen‐Chung Ko, et al.. (2023). Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review. Infectious Diseases and Therapy. 12(3). 919–931. 7 indexed citations

Srivastava, Shashikant, et al.. (2022). Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fiber Model of Mycobacterium kansasii Infection. Antimicrobial Agents and Chemotherapy. 66(4). e0232021–e0232021. 3 indexed citations

Lee, Ming‐Chia, et al.. (2022). Isoniazid level and flu‐like symptoms during rifapentine‐based tuberculosis preventive therapy: A population pharmacokinetic analysis. British Journal of Clinical Pharmacology. 89(2). 714–726. 6 indexed citations

Chidambaram, Vignesh, Marie Gilbert Majella, Samuel K. Ayeh, et al.. (2021). Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis. Clinical Infectious Diseases. 73(9). 1580–1588. 23 indexed citations

Lee, Meng‐Rui, Hung‐Ling Huang, Li‐Ta Keng, et al.. (2021). Establishing Aspergillus-Specific IgG Cut-Off Level for Chronic Pulmonary Aspergillosis Diagnosis: Multicenter Prospective Cohort Study. Journal of Fungi. 7(6). 480–480. 11 indexed citations

Chidambaram, Vignesh, Akshay Gupte, Jann‐Yuan Wang, Jonathan E. Golub, & Petros C. Karakousis. (2020). The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes. Clinical Infectious Diseases. 73(9). e3409–e3418. 9 indexed citations

10.

Tsao, Shih‐Ming, Jann‐Yuan Wang, Chien‐Feng Li, et al.. (2020). Successful treatment of a critical COVID-19 patient with tocilizumab. Journal of the Formosan Medical Association. 120(5). 1276–1278. 1 indexed citations

11.

Wu, Ming‐Fang, Chin‐Chung Shu, Jann‐Yuan Wang, et al.. (2019). NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility. Scientific Reports. 9(1). 13 indexed citations

12.

Wang, Jann‐Yuan, et al.. (2019). Effect of ventilation improvement during a tuberculosis outbreak in underventilated university buildings. Indoor Air. 30(3). 422–432. 56 indexed citations

13.

Lee, Ming‐Chia, Chih‐Hsin Lee, Meng‐Rui Lee, Jann‐Yuan Wang, & Shih‐Ming Chen. (2019). Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study. BMC Infectious Diseases. 19(1). 936–936. 9 indexed citations

14.

Salindri, Argita D., Jann‐Yuan Wang, Hsien-Ho Lin, & Matthew J. Magee. (2019). Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: Retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002–2013. International Journal of Infectious Diseases. 84. 127–130. 25 indexed citations

15.

Huang, Hung‐Ling, Meng‐Hsuan Cheng, Po‐Liang Lu, et al.. (2019). Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease. Respiratory Medicine. 151. 19–26. 11 indexed citations

16.

Lee, Meng‐Rui, Ming‐Chia Lee, Chia‐Hao Chang, et al.. (2019). Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study. Journal of Clinical Medicine. 8(7). 923–923. 14 indexed citations

17.

Shu, Chin‐Chung, Sheng‐Wei Pan, Jia‐Yih Feng, et al.. (2019). The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease. Journal of Clinical Medicine. 8(5). 736–736. 24 indexed citations

18.

Chen, Yen‐Fu, et al.. (2018). Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis. BMC Infectious Diseases. 18(1). 530–530. 4 indexed citations

19.

Wang, Jann‐Yuan, Jann‐Tay Wang, Chia‐Lin Hsu, et al.. (2010). Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis.. PubMed. 14(1). 65–71. 40 indexed citations

20.

Wang, Jann‐Yuan, Po‐Ren Hsueh, Chih‐Hsin Lee, et al.. (2006). Recognising tuberculosis in the lower lung field: an age- and sex-matched controlled study.. PubMed. 10(5). 578–84. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact